Whitepaper/App Note

Whitepaper: Logistic regression model of the endotoxin standard curve and statistical tests

Posted: 19 December 2018 | | No comments yet

The Monocyte Activation Test (MAT) is used to detect or quantify pyrogenic substances that activate human monocytes.

Pyrogenic substances in pharmaceutical products can induce life-threatening fever reactions after injection into the human body. Therefore, it is a regulatory requirement to test such products for pyrogens to ensure product quality and patient safety.

The MAT has been described as a compendial method for pyrogen detection in the European Pharmacopeia since 2010 (Chapter 2.6.30). It is a test that mimics the human reaction to pyrogens, by using a source of monocytes, which release some interleukins upon activation by pyrogenic substances:

MilliporeSigma

The rest of this content is restricted - login or subscribe free to access

European Pharmaceutical Review issue 1 2019 coverThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Related organisations

Send this to a friend